Lara Devgan NAD+ Glutathione Serum is designed for those who see skincare as a long-term investment in cellular health
A majority of individuals currently taking a GLP-1 for weight loss plan to continue for less than two more years, and 90% of those who had discontinued use were on the medication for less than one year
Retatrutide demonstrated greater weight loss than survodutide in their respective Phase 2 trials (24.2% vs 18.7%), likely driven by its unique triple-agonist mechanism that adds GIP receptor activation
Interestingly, observational data from 200 WeightWatchers members showed that those who stopped GLP-1 medications while following a structured healthy habits program not only maintained their weight loss but even lost an additional 1.8% of their body weight over 13 weeks
Ethics statement The animal study was reviewed and approved by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), New Delhi, India, and the Departmental Animal Ethical Committee (DAEC) of the University of Rajasthan, Centre for Advanced studies (CAS), Jaipur, India, has approved this study vide approval number 1678/90/re/S/12/CPCSEA dated 16 June, 2017
